Lantern Pharma Inc
(LTRN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 33,020 | 37,743 | 39,799 | 43,363 | 46,652 |
| Marketable Securities | 19,061 | 17,994 | 18,569 | 18,787 | 18,565 |
| TOTAL | $55,168 | $58,723 | $62,020 | $65,663 | $67,663 |
| Non-Current Assets | |||||
| PPE Net | 54 | 48 | 44 | 40 | 28 |
| Other Non-Current Assets | 288 | 66 | 101 | 677 | 711 |
| TOTAL | $342 | $114 | $145 | $717 | $739 |
| Total Assets | $55,509 | $58,836 | $62,164 | $66,380 | $68,403 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,674 | 2,745 | 3,047 | 5,174 | 2,919 |
| TOTAL | $2,793 | $2,798 | $3,139 | $5,304 | $3,074 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 141 | 0 | 0 | 0 | 13 |
| TOTAL | $141 | $N/A | $N/A | $N/A | $13 |
| Total Liabilities | $2,934 | $2,798 | $3,139 | $5,304 | $3,087 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,857 | 10,857 | 10,857 | 10,831 | 10,831 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -43,151 | -39,283 | -35,902 | -33,637 | -29,145 |
| Other shareholders' equity | -300 | -371 | -435 | -349 | -312 |
| TOTAL | $52,576 | $56,038 | $59,025 | $61,076 | $65,315 |
| Total Liabilities And Equity | $55,509 | $58,836 | $62,164 | $66,380 | $68,403 |